and people with early alzheimer's.f we just look at the early, early individuals living with dementia, it may be more around a million people. ultimately of course, would like to help everybody -- we would like to help everybody. but this would be a huge step forward. kristen: what types of treatments are available now to stave off the symptoms? i understand there is no cure yet. but what is on the horizon for that as well? >> there is no way to cure alzheimer's. there are two other similar drugs that are fda approved, both focusing on amyloid, however in the pipeline, in clinical trials, there are over 100 different types of drugs being looked at. we expect over the next year, the next two years that we are going to see different types of treatments. right now the best thing we can all do to try to stave off alzheimer's is take care of our heart health, make sure if we have high blood pressure that we are treating that, eat well, exercise, sleep well, all of those things that are good for heart health are good for bra

there is new reason for hope in the battle against alzheimer's.or trials, and experimental club -- drug has been shown to slow down the disease significantly that could have global implications. the who estimates more than 55 million people are living with dementia, the most common form of which is alzheimer's. that figure, which is expected to rise to 78 million by 2030 will spike to 139 million two decades after that. the alzheimer's association in the united states says more than 6 million americans are currently living with the disease. our medical editor has been looking into the new drug and has more. reporter: still awaiting the full results, but this does look like another highly significant moment. after decades of failed trials, there are now two antibody drugs which could slow early-stage alzheimer's disease. the drug is given as a monthly infusion, it works by clearing a protein which builds up in sticky clumps in the brains of alzheimer's patients. in the trial, it slowed cognitive decline by about 35% over 18 months in a group of nea

on the alzheimer's, the budgeting issue. and on the parkinson's, what breakthroughs, what are you seeing in your research? >> alzheimer's disease research, we are clearly at a very exciting juncture as you may have seen in the news. to be perfectly clear, the outcome of congressional support and nih funded research has led to clinical trials which are now shooing effects for the first necessary funds to continue research in this area are important as we recognize it in the brain. no one treatment is likely to be sufficient for all. there are now some 59 early stage, phase i and phase ii clinical trials, only eight of which are targeted to amyloid. the other 51 towards other diverse targets such as inflammation, protein folding and ultimately is going to the ability to personalize which of these is most effective for individuals. so your question about budget and momentum reflects on the fact that if there were a limit in resources, we would of course, do our best to ration them appropriately. but i mean a slowing of this who

alzheimer's is also one of our nations most costly diseases. and it is one of the leading causes of death among. as the senator representing the oldest state in the nation, this is of particular concern to me. and as a person who lost her father, her grandfather and two uncles to this devastating disease, i know personally what this means to american families. so, i my question. first, doctor hodes i want to commend the national institute of aging. you have been essential in your institute and sustaining the progress we have been making. we have seen an exciting new class of treatments. one announceda just yesterday that is similar to another that has been approved under the dele onset of alzheimer's the release three data nih said although nih did not fund the study, our research paved the way for this alzheimer trial that notably met its primary and secondary endpoints. i agree. that is why i'm so frustrated these new therapies based on sound science, approved by fda are not reaching patients because of cms and explicable the termination that

and could this be a breakthrough in the battle against alzheimer's?ew drug appears to significantly slow down the progress of the disease. as rehearsals continue for the coronation of king charles iii, police warn of swift action against any protestors on the big day. live from our studio in singapore. this is bbc news. it's newsday. welcome to bbc news, broadcasting to viewers in the uk and around the world. we begin in moscow — where russia has accused ukraine of trying to assasinate president vladamir putin. ukraine says it had nothing to do with the incident in which a drone was seen flying over the kremlin before a small explosion. presdeint zelensky said kyiv only fought russia on ukrainian territory. our russia editor steve rosenberg sent this report from moscow. flying in from the left, what appears to be a drone. then an explosion over the kremlin. this footage is unverified, but the kremlin says that overnight, two drones targeted the residence of the president. moscow blames ukraine, but says that no—one was injured. on russian state tv, a

there's new reason for hope in the battle against alzheimer's.xperimental drug called donanemab has been shown to slow down the progress of the disease significantly. and that could have global implications. the world health organization estimates that more than 55 million people are living with dementia, the most common form of which is alzheimer's. that figure which is expected to rise to 78 million by 2030. and it will spike to 139 million, two decades after that. the alzheimer's association in the us says more than 6 million americans are currently living with the disease. our medical editor fergus walsh has been looking into the new drug, and has more. like this is like a highly significant moment. there are now two antibody drugs which can slow early stage alzheimer's disease. the drug is called donanemab and it's given is a monthly infusion. it works by clearing a rogue protein called amyloid which builds up in sticky clumps in the brains of alzheimer's patients. in a trial, it slowed cognitive decline by around 35% over 18 months in a gro

. >> coming up next some potential good news on alzheimer's, some startling new research into alzheimer'sists searching for ways to better prevent it and treat it. dr. sanjay gupta joins us next. ♪ ♪ ♪ ♪ get 2.9% apr for 36 months plus $1,500 purchase allowance on an xt5 and xt6 when you finance through cadillac financial. ♪ my dad was a hard worker. he used to do side jobs installing windows, charging something like a hundred bucks a window when other guys were charging four to five-hundred bucks. he just didn't wanna do that. he was proud of the price he was charging. ♪ my dad instilled in me, always put the people before the money. be proud of offering a good product at a fair price. i think he'd be extremely proud of me, yeah. ♪ we're carvana we created a brand new way for you to sell your car go to carvana answer a few questions and our techno wizardry calculates your car's value and gives you a real offer in seconds we'll come to you pay you on the spot then pick up your car that's it at carvana >>> it's rare to get some good news related to alzheimer's but researchers now say they'

dementia researchers say we're now entering a new era where alzheimer's is treatable. disease. so what we now need, when we have the full results, is for the regulators to make quick decisions so that patients that could benefit from these treatments are able to benefit. now we don't know how much donanemab will cost, but lecanemab is over £20,000 a year per patient in the us, where it's already licensed. dementia specialists say we'll need a complete overhaul of alzheimer's services here, including access to specialist brain scans if patients are to benefit from these new drugs. police in the us city of atlanta are searching for an active shooter who opened fire in the midtown area. they say a 39—year—old woman died after being shot in a hospital waiting room. four others — all women — are in a critical condition. the authorities are looking for a 24—year—old man who is thought to have carjacked a vehicle nearby and escaped. 0fficers warn that the suspect is armed and dangerous. we were called just down the street to 1110 west peachtree, this is a medicalfacility, the

. >> coming up next, a potential good news on alzheimer's, startling new research into alzheimer's diseasesearching for ways to better prevent it and treat it. doctor sanjay gupta joins us next. qualified to do this? - what? - especially when it comes to your finances. - are you a certified financial planner™? - i'm a cfp® professional. - cfp® professionals are committed to acting in your best interest. that's why it's gotta be a cfp®. julian's about to learn that free food is a personal eating trigger. no, it isn't. (sigh) yes, it is. and that's just a bit of psychology julian learned from noom weight. sign up now at noom.com. ♪ pets are raw. raw curiosity. raw love. raw energy. no dog ever thought, “what if someone sees me like this?” no cat ever asked permission before taking up residence on your keyboard. raw is all pets are, and raw is all they need. raw attention. raw affection. and raw food. like what we make here at stella & chewy's. when the davises booked their vrbo vacation home, they didn't know about this view. or the 200-year-old tree in the backyard. or their neighbors down

could this be a breakthrough in the battle against alzheimer's? new drug appears to slow down significantly the progress of the disease. a 13—year—old boy in serbia is accused of shooting dead eight children and a security guard at a school. as rehearsals continue for the coronation, police warn of swift action against any protestors on the big day. erling haaland, looking for this record here. he's done it. and erling haaland breaks the record for most premier league goals in a season as manchester city return to the top of the table. on newsnight at 10.30pm: did ukraine fly the drones at the kremlin that humiliated russia, and what will putin do next? and how a brand of beer has become the latest target in the us culture wars. good evening, russia has accused ukraine of trying to kill president putin by launching two drone strikes on the kremlin. unverified footage on social media appears to show an object flying over the kremlin before a small explosion. ukraine says it had nothing to do with it. russian officials say they disabled the drones a

petersburg polytechnic university has been studying alzheimer's disease since 2012

a breakthrough in the battle for alzheimer's. major clinical trials find another new drug that appears to slow down the progress of the brain disease signifcantly. a struggle for survival after the catch collapses. night—time rehearsals for the coronation of the king and queen, as thousands of ceremonial troops get ready for the role in the procession on saturday. on bbc london, 20,000 council homes started, but is it enough to solve the housing crisis? and the mp trying to force a change in the law on ultra low emission zones. good evening and welcome to the bbc news at six. russia has accused ukraine of trying kill president putin by launching two drone strikes on the kremlin. unverified footage on social media appears to show an object flying over the kremlin before a small explosion. ukraine said it had nothing to do with it. russian officials say they disabled the drones and have described it as a terrorist act. our russia editor, steve rosenberg, is in moscow for us. steve. it was strange, earlier today, the kremlin spokesm

alzheimer's. all— newspapers is a bunch of lies. alzheimer's. all simers is caused— alzheimer's.hibit the symptoms. that's one thing. but the symptoms. that's one thing. put a— the symptoms. that's one thing. but a restricted— the symptoms. that's one thing. but a restricted carb thing, retraine— but a restricted carb thing, retueipe tpe— but a restricted carb thing, reducing the amount of glucose in reducing the amount of glucose ip wow— reducing the amount of glucose in your trap,— reducing the amount of glucose in your brain, your— reducing the amount of glucose in your brain, your brain can't paptte— in your brain, your brain can't paptte tpe— in your brain, your brain can't handle the glucose . it probably handle the glucose. it probably reates— handle the glucose. it probably creates some— handle the glucose. it probably creates some kind— handle the glucose. it probably creates some kind of amyloid protein,— creates some kind of amyloid protein, which— creates some kind of amyloid protein, which they now protein, which they are now going— protein, which they are now going

so people with alzheimer's have these plaques, and we didn't know whether you get alzheimer's and gethe plaque buildup or get the plaque buildup and then get alzheimer's. it looks more and more likely there's a cause and effect of this amyloid backup, which is not always elderly people. sometimes you see the anecdotes where people are 50 years old and get horrible alzheimer's. >> what's the difference between alzheimer's and dementia >> even when they say alzheimer's, they call it a heterogenous diagnosis because it's so many things. dementia, senility, alzheimer's. i think it's sort of a wide -- covers a wide swath of things. this would be good. >> it would be great. >>> meantime big news in tv land because major shows including late night show with jimmy fallon and jimmy kimmel and steven colbert third quarter went dark after the movie and tv writers went on strike members of the writers guild of america picketed outside entertainment companies in lachl and new york both sides say no future talks are currently scheduled. this could be a long and protracted battle. it feels that way

alzheimer's. all— newspapers is a bunch of lies. alzheimer's. all simers is asei— alzheimer's.. that's one thing. but a restricted carb thing, reiaeing— but a restricted carb thing, reiaeing ine— but a restricted carb thing, reducing the amount of glucose in wow— reducing the amount of glucose in your brain— reducing the amount of glucose in your brain, your— reducing the amount of glucose in your brain, your brain can't naniie— in your brain, your brain can't naniie ine— in your brain, your brain can't handle the glucose . it probably handle the glucose. it probably oreaesi— handle the glucose. it probably creates some— handle the glucose. it probably creates some kind— handle the glucose. it probably creates some kind of amyloid proiein— creates some kind of amyloid protein, which— creates some kind of amyloid protein, which they now protein, which they are now going— protein, which they are now going io— protein, which they are now going ro give— protein, which they are now going to give some kind of drug to going to give some kind of drug io-wnen— going to give some kind of

so the symptoms for diseases like alzheimer's - diseases like alzheimer's diseases like alzheimer's diseaser memory, your speech, your navigation and its different for everybody. that makes a real challenge and is really difficult to get a really objective measure of how people doing over time.— doing over time. alzheimer's research uk's _ doing over time. alzheimer's research uk's early - doing over time. alzheimer'sj research uk's early detection of neurodegenerative to —— diseases, eden project, uses wearables and other technologies.- wearables and other technolouies. , ., , technologies. the question is whether technology - technologies. the question is whether technology helps - technologies. the question is whether technology helps us| technologies. the question is l whether technology helps us to improve the sensitivity with which we are measuring things. it is a question which could be answered in the not to distant future. now, for many people around the world subtitles are vital. in fact, you might be using them on screen right now, but the problem is that most of the time there i

jorge: hay un nuevo medicamento en contra del alzheimer que podrÍa estar dando buenos resultados comol buscan pistas donde hace dÍas ocurriÓ el Último ataque. malherida la mujer sobreviviÓ despuÉs de que el atacante la apuÑalÓ a travÉs de la tela de la carpa donde vivÍa. christine vivÍa en la carpa de al lado. >> empezÓ a gritar la seÑora que lo ayudara. luis: dice que ella misma pudo ser la vÍctima porque el enojo del asesino no discrimina. >> no le importÓ que habÍan dos carpas alrededor, que habÍa un perro en la carpa. simplemente tenÍa rabia. luis: los tres crÍmenes ocurrieron en menos de una semana en un Área cercana a la universidad. el segundo asesinato ocurriÓ en este parque el sÁbado por la noche, cuando un estudiante universitario de apenas 20 aÑos a semanas de graduarse regresaba caminando hacia su casa, el estudiante fue asesinado a puÑaladas, el asesino lo esperaba entre las sombras. su muerte tiene todos los estudiantes tristes y nerviosos. >> saber que algo asÍ pasÓ, y mÁs a un estudiante, me hace pensar que me puede pasar a mÍ. luis: la otra vÍctima fue un hombre de 50

, because she is sitting next to me thinking she doesn't have alzheimer's.rd position of being on the phone to whoever, the utility company, she is claiming she doesn't have alzheimer's, the woman on the phone saying she needs to get her name and address.— phone saying she needs to get her name and address. charlotte, i was in exactly the _ name and address. charlotte, i was in exactly the same _ name and address. charlotte, i was in exactly the same position. - name and address. charlotte, i was in exactly the same position. i - in exactly the same position. i remember trying to cancel his car insurance because he had his licence taken away. they wanted to speak to him. i had a one—year—old on my knee and he kept saying, what are they asking, what do they need to know? the stress that that builds within you enormous. it is the stress that that builds within you enormous.— the stress that that builds within you enormous._ but i the stress that that builds within i you enormous._ but what you enormous. it is huge. but what we found and _ you enormous. it is h

this policy shift impact the markets >>> plus, eli lilly's big breakthrough their experimental alzheimer's drug appears to slow symptoms. the ceo saying this is a significant step forward the stock surging to an all-time high. >>> and later, crude's climb, now crumbling. now back below 70 bucks a barrel starbucks grande-sized fall and the options action on apple ahead of tomorrow's results. i'm melissa lee, this is "fast money. on the desk tonight, tim, karen, steve, and dan a third day of losses following the fed's decision to lift rates by another quarter point the dow sliding 270 points the s&p and the nasdaq going lower. the fed chair indicating that after ten rate hikes in a row, there are no plans for rate cuts, because of stubbornly high inflation. if the fed pauses and higher for longer scenario, then what's next for this market tim? what do you think? >> well, this was as expected. this was -- this is a fed that's gone ten straight times. everyone knows these numbers and you have a case where you've got a jobs market that's still stubbornly tight we've had data this week that's be

borja: en mÁs temas de salud, el caso de un colombiano que no desarrollÓ alzheimer como se pronosticÓlucha contra esta enfermedad,. hay algunos tÉrminos complicados, espero que en casa metiÉndome para ver si logro explicÁrselos, el hombre provenÍa de una numerosa familias de antioquÍa tras su muerte los cientÍficos estudiaron su cerebro, y encontraron que estaba cargado de amiloide tÍpico de las personas con alzheimer, su cerebro fue protegido por un extraÑo cambio de un gen que codifica una proteÍna que ayuda a las cÉlulas cervezas para poder comunicarse. los cientÍficos estudian quÉ ocasionÓ este extraÑocambio en este gen y cÓmo podrÍa duplicar el proceso que ocurriÓ en el paciente colombiano, se trata de un nuevo camino que aÚn hay que recorrer, pero da mucha esperanza y luz para luchar en contra de esta enfermedad con las personas que han vivido y han tenido familiares con el alzheimer, es tremendamente. carolina: hay esperanzas a esta hora, es lo mÁs importante, tambiÉn para lo siguiente, porque aquÍ el dato del dÍa de la "ediciÓn digital", si estÁs deprimido, al menos no estÁ so

alzheimer's. all— newspapers is a bunch of lies. alzheimer's. all simers is asei— alzheimer's.. that's one thing. but a restricted carb thing, reiaeing— but a restricted carb thing, reiaeing ine— but a restricted carb thing, reducing the amount of glucose in wow— reducing the amount of glucose in your brain— reducing the amount of glucose in your brain, your— reducing the amount of glucose in your brain, your brain can't naniie— in your brain, your brain can't naniie ine— in your brain, your brain can't handle the glucose . it probably handle the glucose. it probably oreaesi— handle the glucose. it probably creates some— handle the glucose. it probably creates some kind— handle the glucose. it probably creates some kind of amyloid proiein— creates some kind of amyloid protein, which— creates some kind of amyloid protein, which they now protein, which they are now going— protein, which they are now going io— protein, which they are now going ro give— protein, which they are now going to give some kind of drug to going to give some kind of drug io-wnen— going to give some kind of

before there is promising news in the fight against alzheimer's.nce it's drug appears to be slowing the progression of that terrible disease. it's been an 18 month clinical trial look at this and found 35% of those showed cognitive decline while 39% were less likely to advance to the next stage about. 47% showed no disease progression a year after treatment. apparently stopping alzheimer's in its tracks. is this too good to be true? dr. janette nesheiwat joins us now. this seems to be an amazing breakthrough. do you have faith in this new drug and what does the new studies show you? >> hey eric, yes, i do have faith in the student drug. we've got to see what the phase three trial data outcome is what should be out by the end of next month. some of the study found is about 1700 participants between the ages of c and 85 about 71% of them in a decrease in the amount of plaque buildup in their brain after one year of this medicine which is an iv infusion you get once a month. just think about your plaque build of these build up in your brain, what it d

and we met at then did you see the risk of alzheimer's disease in the entire community?that might be a possibility? so for example, we use the dusable energy or the renewable energies, maybe using electronic vehicles. um you know those normal cars that might potentially reduce the uh, emission of the air pollution particular matter in the community, and that may eventually help us reduce the alzheimer disease. really appreciate you coming on to talk with us about these study findings. thank you again for your time this afternoon. thank you very much. i knew. united nations report estimates climate related events have killed over 2 million people over the past half century. in addition to thd meteorological organization estimates the damage to global economies from climate events have totaled over $4 trillion. this report comes as the agency looks to improve early warning systems, which have helped to save lives during disasters, including tropical cyclones, which reportedly took the biggest toll on humans. and economies alright and unusual turn of events at a high profil

alzheimer's society . we're alzheimer's society. of the day, including the things that channels just that the other channels just wont—it- that the other channels just won-t—it ite- won't talk about. if it's happening— won't talk about. if it's happening, happening happening, it's happening here. woke— happening, it's happening here. wake-mornings- happening, it's happening here.- wake-mornings-news wake up two mornings on gb news as wake up two mornings on gb news oe-ieotte-e— wake up two mornings on gb news as-people's channel,- as the people's channel, iritoin-e— as the people's channel, britain's news- as the people's channel, britain's news . channel very good afternoon. you're with gb - very good afternoon. you're win it weve— - very good afternoon. you're with gb news live.— . very good afternoon. you're with gb news live. i'm- . very good afternoon. you're with gb news live. i'm mark- with gb news live. i'm mark tongnoret— with gb news live. i'm mark longhurst and— with gb news live. i'm mark longhurst and coming up for you

petersburg polytechnic institute , alzheimer's disease has been studied since 2012. recently , scientists have officially announced that they have made serious progress in their research. we found the structure of the chemical structure, as well, which may be the prototype of the medicinal drug. preclinical trials have shown that the drugs found successfully overcome the internal barrier separating the central nervous system from the general environment of the body and quite quickly, according to experts, end up in the brain. that is, where it is required for this disease. right now i have here, uh, in a test tube are our substance to be followed. and here it is at a concentration of 20 million oe, we briefly call it c-20, this is the same derivative of benzopyran. the experiments were carried out on laboratory mice, in which before the experiment it was noted the so-called alzheimer's model of memory lapses to the point that rodents forgot life-threatening situations and were not afraid of potential threats. we are able to restore with the help of this substance. uh

and a new alzheimer's _ our historical responsibility.nd a new alzheimer's drug has - our historical responsibility. and a new alzheimer's drug has been i our historical responsibility. and a new alzheimer's drug has been shown to slow the disease by about one third. there are two days to go to the coronation of king charles and camilla the queen consort. the king will be the 40th monarch crowned at westminster abbey since 1066, and millions of people are expected watch the event in this country and around the world. final preparations are under way. our correspondent charlotte gallagher reports. two days to go, and the coronation campers are ready to celebrate. some of these people have been here for days already, so determined to get a good view on saturday. great britain and america. for donna and maryjane, it's also a chance for a catch up. they met 12 years ago at the wedding of the prince and princess of wales and have attended royal events together ever since. we started yesterday and we'll be here, you know, through saturday night

that eli little's new drug for alzheimer's slowed decline in alzheimer's, what do you think? on phase three trials. this might be a game-changer, liz. the study found out about 1700 participants between the age of 60 and5, there was 35% decrease in cognitive decline which is fantastic. with this new medication, iv infusion, a monthly infusion, it reduces amy lloyd plaque build up in the brain. it kills your brain cells, confusion, changes in mood, inability to do basic things in life, drive a car, balance a checkbook. i'm excited about this. let's see what the trials show. liz: biogen, and alzheimer's drug reduces plaque by 70%. genentech has a drug that is promising too. we have the directors for centers of medicare and medicaid, testifying that medicare may help cover the cost of that good stuff. final word, doctor? >> right now, alzheimer's dementia most common cause of dementia, costs $345 billion every year. we need to protect seniors. improve the quality of life. liz: i love of the story, optimism, hope for some families. dr. nebuchadnezzer we'll stay on the blockbuster

. >>> the fight against alzheimer's tonight. there is news this evening the early results of a new alzheimer's drug and it is encouraging. >>> willie nelson, missy elliott, george michael all in the news tonight. >>> america strong this evening. the service dog in the moment. millions have now watched it and you won't forget it. >>> from abc news world headquarters in new york, this is "world news tonight" with david muir. >>> good evening. great to have you with us on wednesday night. late reporting on russia tonight claiming ukraine tried to kill vladimir putin. what president zelenskyy is saying and what the biden administration is saying. you will see the video here. major questions surrounding it. >>> we begin tonight with this urgent manhunt underway right now after a gunman opened fire in a doctor's office in downtown atlanta. multiple victims tonight. one person dead and at least others wounded and rushed to the hospital. a suspect tried to carjack a car in the parking lot managing to carjack another car right after. ton

dan: a rally for alzheimer's drugs kicked off today in san francisco.bers gathered at the city's federal building this morning. more than 100 advocates are calling for coverage and the first-ever fda-approved treatments for alzheimer's disease. it is in response to the centers for medicare and medicaid insurance decision to not cover costs for the medication. some caregivers say it will buy more time in good years for people who have alzheimer's if they use this particular drug. >> if you are living with alzheimer's, the clock is ticking, and we need to change it immediately. dan: the drug suspected to be officially approved by the fda in july. ama: still ahead, remember in the life and legacy of tina turner. why she did not like her hit song, "what's love got t ama: the moral day we get is typically considered the start of the boating season -- memorial day weekend is typically considered the start of the boating season. gu oicer theas conational weather service, and san francisco fire department teamed up to get the word out about boating safety. we a

in the alzheimer's area.not easy drug to pronounce or spell but it's easy to understand why the fda is so excited. it did show across all clinical end points a slowing of the progression of alzheimer's by more than a third. that is unprecedented. let's hope those results hold. they studied 1700 patients over the last 18 months and compared to the 29% in a placebo controlled group that showed no decline in cognitive function, 47% showed no decline with this drug. very exciting news. it's pricey but david riggs is doing a great job. maria: that's a great comment. i agree, these are the biggest issues and obviously the company is doing well with it. how come it's been so hard to crack this alzheimer's disease issue? i mean, we saw biogen, a couple of drugs on the market but they couldn't get to the finish line? what do you say about what is going onto and the fact that eli lily has had success maybe encourages others to also continue researching and trying to push drugs forward for this. >> that's right, novo is

but unique to a*lgz, alzheimer's -- alzheimer's, medicare beneficiaries paid into that program their entire life and they have access to every other type of african american suit cal for every other condition but not alzheimer's. i'm just pointing out that flaw in the current system. that needs to change. sen. markey: what i'm saying is $25,000 a year is too high. and it's the ask that then goes to the system, then people are then afraid would have an excessively impossible system for the -- impossible burden for the system to be able to carry. then it comes back into your court to see what you can do to lower that price, as you're looking at this vast number. we have 15 million baby boomers who are going to have alzheimer's and that's just for our country. a global issue obviously. your market's going to be massive and $25,000 per year is just too extraordinarily high. >> thank you, senator marky. senator -- senator markey. sen. cassidy: i felt i must address spread pricing. both of y'all spoke of things that your organizations are doing to address some of the market distortions. i

petersburg polytechnic institute has been studying alzheimer's disease since 2012. recently, scientists have officially announced that they have made significant progress in their research. we have found a structure, a chemical structure, as well, which may be the prototype of a drug. preclinical trials have shown the found funds successfully overcomes the internal barrier separating the central nervous system from the general environment of the body and pretty quickly the tomboys of the experts, turns into the brain. that is, where it is required for this disease. right now i have here, uh, the vial contains our substance to follow. and here it is at a concentration of 20 mmol. we briefly call it mine at home . life-threatening situations and were not afraid of potential threats. with the help of this substance, we are able to restore memory, fear in mice. there are still many tests ahead , the new drug needs to be tested for toxicity , mutagenicity, and the optimal therapeutic dose should be selected. if everything goes well, the next stage of clinical trials. i t

. >>> and researchers say a major clue to protect people from alzheimer's disease.head, one man who defied the odds for decades may have cracked gene code. dr. sanjay gupta is going to join us ahead to explain. know ? am i? ya! save 50% on ththe sleep number limited edition smart bed. plus, special financing. only at sleep numberer. i will be a travel influencer... hey, i thought you were on vacation? it's too expensive. use priceline, they've got deals no one else has. what about work? i got you. looking great you guys! ♪ go to your happy price ♪ ♪ priceline ♪ >> woman: why did we choose safelite? >> vo: for us, driving around is the only way we can get our baby to sleep, so when our windshield cracked, we needed it fixed right. we went to safelite.com. there's no one else we'd trust. their experts replaced our windshield, and recalibrated our car's advanced safety system. they focus on our safety... so we can focus on this little guy. >> singers: ♪ safelite repair, safelite replace. ♪ - this is our premium platinum coverage map and this is consumer cellular's map.

so the symptoms for diseases like alzheimer's disease are really, really broad.e walking, your memory, your speech, your navigation and it's different for everybody. so that makes it a real challenge and it's really difficult to get a really objective measure of how people are doing over time. alzheimer's research uk's early detection of neurodegenerative diseases, eden project, uses wearables and other technologies. the question is whether technology can actually help us to become more objective about what we're seeing and sort of improve the sensitivity with which we're measuring things. it's a question which could be answered in the not too distant future. now, for many people around the world, subtitles are vital. in fact, you might be using them on screen right now. but the problem is that most of the time there isn't a screen in front of us. well, actually, there is quite a lot at the time. but for people that are deaf or hard of hearing, sometimes when they're trying to follow a conversation, it can be challenging. there are ways to get subtitles when you'

fight against alzheimer's.w experimental drug significantly slowed cognitive decline, that's the ability to think clearly and do daily activities, slowed that decline by 35%. the drug could soon go to the fda for approval. cnn medical correspondent meg terrell joins us now. first of all, meg, welcome. it's great to have you here. walk us through this drug and how it works. >> well, john, alzheimer's advocates are calling this the most exciting phase 3 alzheimer's data to date. they're saying this could mag a significant impact on the progression of this disease. so we know that alzheimer's is characterized by these plaque buildups in the brain called amyloid and this one works in particular by slowing that plaque. in studies we have a brain scan that shows two patients that got the drug and that significantly reduced their plaques in the brain over time. they're the yellow kind of disappearing on that slide versus the patient that got the placebo and didn't get the drug and the brain plaques are still there in

has dramatic development that could have applications as well when it comes to parkinson's and alzheimer'sat was discovered this week because of an nih grant, the national institutes oftu health grant. millions ofse dollars to these researchers that could transform the way we treat brain cancer in america as well as parkinson's and alzheimer's so what does he want to do with of the budget of this agency the national institutes of health he wants to cut it 20 to 25%. that same outrage to think that we would forestall the research that could save lives and alleviate suffering across america. the fact that the leadership in the world and medical research would be jeopardized because of gamesmanship by speaker mccarthy of the issue of the debt ceiling his proposal for the budget if you want to call it that they are determined to preserve the tax cuts at any expense and when you look to 20 to 25% it is true that they will go to an extreme. what would the default look like? trillions of dollars in savings by families across america and the 4o1k would take a beating. it would kill jobs and force

you likely showing positive results for stage iii alzheimer's study. after treatment, 47% of participants show no further cognitive decline. in one of the stocks on strata, 4%. interest rates, where are we? ten year treasury yield well below three and a half%. down to 339. the ten year treasury -- two year treasury well below 4%, back to 395. oil, the decline continues. 5% drop yesterday. today we've dropped below $70 a barrel, 6928 to be precise. gas down 1 cent overnight but that will change. expect gas prices to decline sharply starting again this weekend. on the show today, the president said several times he never discussed business with his son will hunter. new e-mails show white house business meetings for his business partners. the hunter story made up become an issue for 2024. the administration since 1500 active-duty troops to the southern border but they will not keeping migrants out, they will be processing them more efficiently into the country. when title 42 ends, 10000 migrants a day are expected. we will take you to one of the most expe

some did not have an escali of alzheimer's disease. and so we looked.fe our habits can affect the development of alzheimer's here. i want to start by showing you an amazing one. what is mind and memory is we look into the deepest depths of the brain, to put it briefly mind and memory are nerve cells and processes. you see shoots growing from all cells. this is how the monuments are formed, all the cells are connected to each other by these processes and form something thanks to which we then, for example, read poetry or, i don’t know, play the piano or just learn, learn. here any training is the formation of these nervous otkrozdkov. but this is the death of a nerve cell. an absolutely dramatic thing , the shoots are leaving more and more communication with no one , more life. no. here is such an amazing science that they determined what they said about this, we will talk with an amazing person , the famous actor yevgeny vladimirovich knyazev our guest today is not ivy. take care of the hop. well, that's better. come on this life what are you doing wide

both my grandparents died with alzheimer, so for me, this is a very meaningful voyage and mission toople and their families who suffer from these terrible neurodegenerative diseases. it's system uses a computer with a webcam and that's it. we use standard video and enhance it with software to basically compensate for low frame rate and other limitations of standard video and create a signature of both the disease and its progression. it looks at how the eyes behave when shown specific stimuli and measures their characteristics over time. the goal: to precisely chart and ultimately diagnose disease much sooner than it is today, from years down to months. and i'm having a go of their demo test. first task. follow the red dot. you'll see itjumping on the screen. and your task is simply to follow it. 0k. what we're actually measuring is the response time and the ability of your brain to calculate ahead of time where it needs to reach at the end. right. by digitally mapping the position of my face and features, it's able to precisely track my eyes�* micro—movements without the need to res

— now to head of policy at alzheimer's research david alzheimer's research uk, david inomoo— alzheimer'slater stage trial is looking at oiooi 2000— later stage trial is looking at about 2000 people. the the noooo— about 2000 people. the the roooo inor— about 2000 people. the the process that they are now nooiing— process that they are now heading into— process that they are now heading into is- process that they are now heading into is the approval noooo— heading into is the approval roooo io— heading into is the approval process to firstly to for regulators— process to firstly to for regulators across the world to iooiio— regulators across the world to decide whether— regulators across the world to decide whether they are safe and oiiooiiwo— decide whether they are safe and oiiooiiwo ior— decide whether they are safe and effective for use— decide whether they are safe and effective for use in— decide whether they are safe and effective for use in people with oonw— effective for use in people with early alzheimer's— effective for use in people with early alzheimer's disease and mom— earl

. >>> well, still to come, a possible new tool in the fight against alzheimer's disease. benin.dad's side. 30% japanese. thank you, mom. there's just still so much to discover. now on sale for mother's day. i have moderate to severe ulcerative colitis. so i'm taking zeposia, a once-daily pill. so much to discover. because i won't let uc stop me...from being me. zeposia can help people with uc achieve and maintain remission. and has been shown to reduce symptoms in as early as 2 weeks. zeposia is the first and only s1p receptor modulator approved for uc. don't take zeposia if you had a heart attack, chest pain, stroke or mini-stroke, heart failure in the last 6 months, irregular or abnormal heartbeat, if you have untreated sleep apnea, or take maois. zeposia may cause serious side effects including infections that can be life threatening and cause death, slow heart rate, liver or breathing problems, increased blood pressure, macular edema, swelling and narrowing of the brain's blood vessels, and increased risk of pml-- a rare brain infection that usually leads to death or severe

alzheimer's aswant cmshae that g e woulgi people with alzheimer's more access to treatments and buy themt is extremely urgent. if you are living with alzheimer's, the clock is ticking, and it needs to change immediately. dan: one of the medications, leqembi, is expected to be approved in july, which advocates hope will be covered by cvs -- cms. ama: dan: may is national foster care month, a time to highlight the more than 400,000 children living in foster care. a big struggle is finding families to host foster children in their homes. ama: that strobel makes it hard to keep kids in their own -- that struggled makes it hard to keep kids in their own neighborhoods. >> do i talk about both? do i talk about going from one foster family to this foster family? ♪ that we face in marin county, and, quite frankly, across the entire bay area, is we do not have enough foster homes in our area. in marin county alone, we send 40% of foster youth out of our county. i'm a foster parent myself, and loss of my children who have been removed from their families have gone through an extreme amount of traum